Horm Metab Res 2005; 37(5): 281-285
DOI: 10.1055/s-2005-861471
Original Clinical
© Georg Thieme Verlag KG Stuttgart · New York

Angiotensin II Stimulates Cardiac Adrenomedullin Production and Causes Accumulation of Mature Adrenomedullin Independently of Hemodynamic Stress in Vivo

H.  Onitsuka1 , T.  Imamura1 , J.  Yamaga1 , K.  Kuwasako1 , K.  Kitamura1 , T.  Eto1
  • 1 First Department of Internal Medicine, Miyazaki Medical College, University of Miyazaki, Miyazaki, Japan
Weitere Informationen

Publikationsverlauf

Received 19 July 2004

Accepted after revision 4 October 2004

Publikationsdatum:
22. Juni 2005 (online)

Abstract

Adrenomedullin is a potent hypotensive peptide that may act on myocytes to inhibit hypertrophy and on fibroblasts to inhibit growth in vitro induced by mechanical stretching and angiotensin II. Adrenomedullin is processed from the inactive intermediate adrenomedullin precursor with a glycine extension, which is subsequently converted to biologically active mature adrenomedullin by enzymatic amidation. Total adrenomedullin is the sum of intermediate and mature adrenomedullin. We examined the effect of a subpressor dose of angiotensin II on the production of left ventricular adrenomedullin and on protein levels of mature adrenomedullin in the left ventricle in vivo. We also investigated whether the effect is mediated by the angiotensin II type 1 receptor. Concentrations of total and mature adrenomedullin in the left ventricle and mature adrenomedullin-to-intermediate adrenomedullin ratio were significantly increased by angiotensin II infusion, regardless of pressure overload. Total and mature adrenomedullin concentrations significantly correlated with the weight of the left ventricle. Furthermore, increased adrenomedullin gene expression and protein levels were completely suppressed by a subdepressor dose of angiotensin II type 1 receptor blocker. In conclusion, angiotensin II stimulates the production of cardiac adrenomedullin and accumulates mature adrenomedullin in the left ventricle independently of hemodynamic stress. These processes are partially regulated through the angiotensin II type 1 receptor in vivo.

References

  • 1 Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, Eto T. Adrenomedullin: A novel hypotensive peptide isolated from human pheochromocytoma.  Biochem Biophys Res Commun. 1993;  192 553-560
  • 2 Hirano S, Imamura T, Matsuo T, Ishiyama Y, Kato J, Kitamura K, Koiwaya Y, Eto T. Differential responses of circulating and tissue adrenomedullin and gene expression to volume overload.  J Cardiac Failure. 2000;  6 120-129
  • 3 Morimoto A, Nishikimi T, Yoshihara F, Horio T, Nagaya N, Matsuo H, Dohi K, Kangawa K. Ventricular adrenomedullin levels correlate with the extent of cardiac hypertrophy in rats.  Hypertension. 1999;  33 1146-1152
  • 4 Harada K, Komuro I, Shiojima I, Hayashi D, Kudoh S, Mizuno T, Kijima K, Matubara H, Sugaya T, Murakami K, Yazaki Y. Pressure overload induces cardiac hypertrophy in angiotensin II type 1A receptor knockout mice.  Circulation. 1998;  97 1952-1959
  • 5 Baker K M, Chernin M I, Wixson S K, Aceto J F. Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats.  Am J Physiol. 1990;  259 H324-H332
  • 6 Ito H, Hiroe M, Hirata Y, Fujisaki H, Adachi S, Akimoto H, Ohta Y, Marumo F. Endothelin ETA receptor antagonist blocks cardiac hypertrophy provoked by hemodynamic overload.  Circulation. 1994;  89 2198-2203
  • 7 Komuro I. Molecular mechanism of cardiac hypertrophy and development.  Jpn Circ J. 2001;  65 353-358
  • 8 Tsuruda T, Kato J, Kitamura K, Imamura T, Koiwaya Y, Kangawa K, Komuro I, Yazaki Y, Eto T. Enhanced adrenomedullin production by mechanical stretching in cultured rat cardiocytes.  Hypertension. 2000;  35 1210-1214
  • 9 Onitsuka H, Imamura T, Ito K, Kuwasako K, Yamakawa H, Hirano S, Kitamura K, Eto T. Differential gene expression of adrenomedullin receptors in pressure- and volume-overloaded heart: role of angiotensin II.  Peptides. 2004;  25 1107-1114
  • 10 Tsuruda T, Kato J, Kitamura K, Kawamoto M, Kuwasako K, Imamura T, Koiwaya Y, Tsuji T, Kangawa K, Eto T. An autocrine or paracrine role of adrenomedullin in modulating cardiac fibroblast growth.  Cardiovasc Res. 1999;  43 958-967
  • 11 Tsuruda T, Kato J, Kitamura K, Kuwasako K, Imamura T, Koiwaya Y, Tsuji T, Kangawa K, Eto T. Adrenomedullin: A possible autocrine or paracrine inhibition of hypertrophy of cardiomyocytes.  Hypertension. 1998;  31 505-510
  • 12 Kitamura K, Kato J, Kawamoto M, Tanaka M, Chino N, Kangawa K, Eto T. The intermediate form of glycine-extended adrenomedullin is the major circulating molecular form in human plasma.  Biochem Biophys Res Commun. 1998;  244 551-555
  • 13 Hirayama N, Kitamura K, Imamura T, Kato J, Koiwaya Y, Tsuji T, Kangawa K, Eto T. Molecular forms of circulating adrenomedullin in patients with congestive heart failure.  J Endocrinol. 1999;  160 297-303
  • 14 Nishikimi T, Horio T, Kohmoto Y, Yoshihara F, Nagaya N, Inenaga T, Saito M, Teranishi M, Nakamura M, Ohrui M, Kawano Y, Matsuo H, Ishimitsu T, Takishita S, Matsoka H, Kenji K angawa. Molecular forms of plasma and urinary adrenomedullin in normal, essential hypertension and chronic renal failure.  J Hypertens. 2001;  19 765-773
  • 15 Tadokoro K, Nishikimi T, Mori Y, Wang X, Akimoto K, Matsuoka H. Altered gene expression of adrenomedullin and its receptor system and molecular forms of tissue adrenomedullin in left ventricular hypertrophy induced by malignant hypertension.  Regul Peptides. 2003;  112 71-78
  • 16 Yoshida K, Yasujima M, Kohzuki M, Kanazawa M, Yoshinaga K, Abe K. Endothelin-1 augments pressor response to angiotensin II infusion in rats.  Hypertension. 1992;  22 292-297
  • 17 Hirano S, Imamura T, Onitsuka H, Matsuo T, Kitamura K, Koiwaya Y, Eto T. Rapid increase in cardiac adrenomedullin gene expression caused by acute pressure overload: effect of the rennin-angiotensin system on gene expression.  Circ J. 2002;  66 397-402
  • 18 Maltese J Y, Oyarce A M, Eipper B A. Prevalence and turnover of peptidylglycine alpha-amidating monooxygenase mRNA in atrial cardiomyocytes.  J Mol Cell Cardiol. 1996;  28 155-163
  • 19 Chao J, Kato K, Zang J J, Dobrzynski E, Wang C, Agata J, Chao L. Human adrenomedullin gene delivery protects against cardiovascular remodeling and renal injury.  Peptides. 2001;  22 1731-1737
  • 20 Kaiser M, Kahr O, Shimada Y, Smith P, Kelly M, Mahadeva H. et al . Differential regulation of ventricular adrenomedullin and atrial natriuretic peptide gene expression in pressure and volume overload in the rat.  Clin Sci. 1998;  94 359-365
  • 21 Tsuruda T, Kato J, Kitamura K, Mishima K, Imamura T, Koiwaya Y, Kangawa K, Eto T. Roles of protein kinase C and Ca2+-dependent signaling in angiotensin II-induced adrenomedullin production in rat cardiac myocytes.  J Hypertens. 2001;  19 757-763
  • 22 Niu P, Shindo T, Iwata H, Iimuro S, Takeda N, Zhang Y, Ebihara A, Suematsu Y, Kangawa K, Hirata Y, Nagai R. Protective effects of endogenous adrenomedullin on cardiac hypertrophy, fibrosis and renal damage.  Circulation. 2004;  109 1789-1794

Takuroh Imamura, M. D.

First Department of Internal Medicine · Miyazaki Medical College · University of Miyazaki

Kihara 5200 · Kiyotake · Miyazaki 889-1692 · Japan

Telefon: 81-985-85-0872 ·

Fax: 81-985-85-6596

eMail: imatak@med.miyazaki-u.ac.jp